Rezetamig is a human bispecific antibody that recognizes the CD3 antigen on T-lymphocytes and the CD22 antigen on mature and malignant B-lymphocytes[1].
Molecular Weight:
(111.027 kDa)
Purity:
95.65
CAS Number:
[2795115-07-8]
Target:
CD22,CD3
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted